Safety End Points
Patricia Saddier, MD, PhD
Executive Director, Pharmacoepidemiology
Merck & Co., Inc.
West Point, Pennsylvania, United States
Kandace L. Amend
Epidemiologist
Optum
Bloomfield Hills, Michigan, United States
Morgan Marks
Pharmacoepidemiology Department, Merck & Co. Inc., Kenilworth, NJ, USA, United States
Christine Velicer
Pharmacoepidemiology Department, Merck & Co. Inc., Kenilworth, NJ, USA, United States
John D. Seeger, PharmD, FISPE
Optum Epidemiology
Boston, Massachusetts, United States